Howard Hughes Medical Institute’s SolarWinds Corporation Common Stock SWI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-247,973
Closed -$3.52M 22
2021
Q4
$3.52M Hold
247,973
1.38% 18
2021
Q3
$4.15M Sell
247,973
-222,184
-47% -$4.11M 1.4% 19
2021
Q2
$8.38M Hold
470,157
2.8% 15
2021
Q1
$8.65M Hold
470,157
2.95% 14
2020
Q4
$7.41M Sell
470,157
-27,404
-6% -$600K 1.74% 17
2020
Q3
$10.7M Hold
497,561
3.51% 8
2020
Q2
$9.27M Hold
497,561
3.79% 6
2020
Q1
$8.22M Hold
497,561
1.72% 10
2019
Q4
$9.74M Hold
497,561
3.49% 6
2019
Q3
$9.68M Hold
497,561
2.71% 4
2019
Q2
$9.63M Sell
497,561
-28,669
-5% -$564K 4.6% 2
2019
Q1
$10.3M Hold
526,230
2.4% 4
2018
Q4
$7.68M Buy
+526,230
New +$8.25M 2.43% 5

Other funds holding SWI

Howard Hughes Medical Institute's SWI Position: Q1 2022 in Review

Howard Hughes Medical Institute sold out of SolarWinds Corporation Common Stock (SWI) in Q1 2022, closing a stake of 247,973 shares — an estimated $3.52M sold.

Howard Hughes Medical Institute first reported a position in SWI in Q4 2018 and held it in 13 quarters. The position peaked at $10.7M in Q3 2020. 135 funds tracked by Wall St. Rank hold SWI as of Q1 2022.

  • Howard Hughes Medical Institute reported no remaining SolarWinds Corporation Common Stock position as of Q1 2022 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 247,973 SolarWinds Corporation Common Stock shares in Q1 2022, an estimated $3.52M.
  • Howard Hughes Medical Institute first reported a position in SolarWinds Corporation Common Stock in Q4 2018 and held it in 13 quarters.
  • Howard Hughes Medical Institute's SolarWinds Corporation Common Stock position peaked at $10.7M in Q3 2020.
  • 135 funds tracked by Wall St. Rank held SolarWinds Corporation Common Stock as of Q1 2022.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2022, filed 12 May 2022.